Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays-Reference-Cited by-同舟云学术

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays

Published:2014-07-23 Issue:9 Volume:12 Page:1545-1553
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Hillarp A.¹,Gustafsson K. M.²,Faxälv L.²,Strandberg K.¹,Baghaei F.³⁴,Fagerberg Blixter I.³⁴,Berndtsson M.⁵,Lindahl T. L.²

Affiliation:

1. Clinical Chemistry; University and Regional Laboratories Region Skåne; Malmö Sweden

2. Department of Clinical and Experimental Medicine; Linköping University; Linköping Sweden

3. Department of Medicine; Coagulation Center; Sahlgrenska University Hospital; Gothenburg Sweden

4. Department of Clinical Chemistry and Transfusion Medicine; The Sahlgrenska Academy; Institute of Biomedicine, University of Gothenburg; Gothenburg Sweden

5. Department of Clinical Chemistry; Karolinska University Hospital; Stockholm Sweden

Funder

Bristol Meyers Squibb

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12649/fullpdf

Reference24 articles.

1. Novel oral anticoagulants: clinical pharmacology, indications and practical considerations;Harder;Eur J Clin Pharmacol,2013

2. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban;Gong;Can J Cardiol,2013

3. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases;Turpie;Arterioscler Thromb Vasc Biol,2007

4. Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa;Pinto;J Med Chem,2007

5. The safety and efficacy of apixaban: where do we stand in 2013?;de Souza Brito;Expert Opin Drug Saf,2013

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory Evaluation of Interferences Associated with Factor XIa Inhibitors Asundexian and Milvexian in Routine Coagulation Assays;Diagnostics;2024-09-09

2. Measurement of heparin, direct oral anti‐coagulants and other non‐coumarin anti‐coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline;British Journal of Haematology;2024-09-02

3. DOAC‐Remove to counteract the interference of anti‐Xa oral anticoagulants on the monitoring of heparin;International Journal of Laboratory Hematology;2024-05-27

4. An event-oriented diffusion-refinement method for sparse events completion;Scientific Reports;2024-03-21

5. Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients;Scientific Reports;2024-03-21